Zobrazeno 1 - 10
of 1 425
pro vyhledávání: '"L, Lakatos"'
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Current therapeutic strategies for inflammatory bowel disease (IBD) have reached a plateau in the rates of response and/or remission achieved with a single therapeutic agent. Consequently, the advanced combination therapy (ACT) strategy has emerged a
Externí odkaz:
https://doaj.org/article/0b3128bbd95445dc9d6a763958045b24
Autor:
Péter Bacsur, Tamás Resál, Patrícia Sarlós, Ákos Iliás, Liza Dalma Sümegi, Diána Kata, Anett Dávid, Bernadett Farkas, Emese Ivány, Anita Bálint, Zsófia Bősze, Anna Fábián, Renáta Bor, Zoltán Szepes, Waqqas Afif, Talat Bessissow, Klaudia Farkas, Péter L. Lakatos, Tamás Molnár
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: The usability of subcutaneous vedolizumab (s.c. VDZ) treatment in inflammatory bowel diseases (IBD; ulcerative colitis (UC), Crohn’s disease (CD)) has been proven via clinical trials while real-world data collection is ongoing. Objectiv
Externí odkaz:
https://doaj.org/article/c22a45855e894d3eb5843d9997f140aa
Autor:
Laszlo J. Barkai, Lorant Gonczi, Fruzsina Balogh, Dorottya Angyal, Klaudia Farkas, Bernadett Farkas, Tamas Molnar, Tamas Szamosi, Eszter Schafer, Petra A. Golovics, Mark Juhasz, Arpad Patai, Aron Vincze, Patricia Sarlos, Alexandra Farkas, Zsolt Dubravcsik, Tamas G. Toth, Hajnal Szekely, Pal Miheller, Peter L. Lakatos, Akos Ilias
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Long-term data on ustekinumab in real-life Crohn’s disease patients are still missing, though randomized controlled trials demonstrated it as a favorable therapeutic option. We aimed to evaluate ustekinumab's clinical efficacy, drug sustai
Externí odkaz:
https://doaj.org/article/18a9d3318eab411daa58056039b17d6c
Autor:
Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Different endoscopic scoring systems for assessing ulcerative colitis (UC) severity are available. However, most of them are not correlated with disease extent. Objectives: Our study aimed to compare the predictive value of the PanMay sco
Externí odkaz:
https://doaj.org/article/3145a2041e99493e847d9a692c64d678
Autor:
Panu Wetwittayakhlang, Christine Verdon, Michael Starr, Gustavo Drügg Hahn, Petra A. Golovics, Talat Bessissow, Waqqas Afif, Gary Wild, Alain Bitton, Peter L. Lakatos
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 34, Iss 6, Pp 603-610 (2023)
Externí odkaz:
https://doaj.org/article/7b44bebf7a8041698455c9eeeac1543d
Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
Autor:
Livia Lontai, Zsuzsanna Kürti, Lorant Gonczi, Nóra Komlódi, Fruzsina Balogh, Ákos Iliás, Peter L. Lakatos
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 34, Iss 5, Pp 508-515 (2023)
Externí odkaz:
https://doaj.org/article/e352e9d55d57433f9130d57bf132fa08
Autor:
Debora Garza-Hernandez, Maricruz Sepulveda-Villegas, Jose Garcia-Pelaez, Raul Aguirre-Gamboa, Peter L. Lakatos, Karol Estrada, Manuel Martinez-Vazquez, Victor Trevino
Publikováno v:
BMC Genomics, Vol 23, Iss 1, Pp 1-14 (2022)
Abstract Background Crohn’s disease is one of the two categories of inflammatory bowel diseases that affect the gastrointestinal tract. The heritability estimate has been reported to be 0.75. Several genes linked to Crohn’s disease risk have been
Externí odkaz:
https://doaj.org/article/98a73c7a785c461e81087f23fb56386d
Publikováno v:
Case Reports in Gastroenterology, Vol 16, Iss 1, Pp 116-121 (2022)
Crohn’s disease (CD) and Lynch syndrome (LS) are two different entities, yet both are associated with increased risk of colorectal cancer (CRC). We present the case of a young female patient in long-standing remission of her ileocolonic luminal CD,
Externí odkaz:
https://doaj.org/article/b833245b87a347f293adcbcbfabdc3be
Autor:
Jean-Pierre Routy, Bertrand Lebouché, Nicolas Chomont, Stéphane Isnard, Réjean Thomas, Talat Bessissow, Guy Boivin, Alexandra de Pokomandy, Nadine Kronfli, Marina Klein, Cécile Tremblay, Léna Royston, Simeng Bu, Carolina A. Berini, Peter L. Lakatos, Cecilia T. Costiniuk
Publikováno v:
BMJ Open, Vol 13, Iss 1 (2023)
Introduction Chronic cytomegalovirus (CMV) infection is very frequent in people living with HIV (PLWH). High anti-CMV IgG titres, which may be linked to transient CMV replication, have been associated with earlier mortality, CD8 T-cell expansion, low
Externí odkaz:
https://doaj.org/article/2ec15862c3524ef2a20a081bf82f809d
Autor:
Heinfried H. Radeke, Jürgen Stein, Gert Van Assche, Gerhard Rogler, Peter L. Lakatos, Florian Muellershausen, Pierre Moulin, Philip Jarvis, Laurence Colin, Peter Gergely, Wolfgang Kruis
Publikováno v:
Inflammatory Intestinal Diseases, Pp 1-11 (2020)
Background and Aims: KRP203 is a potent oral agonist of the sphingosine-1-phosphate receptor subtype 1 that induces the sequestration of peripheral lymphocytes, thereby potentially reducing the number of activated lymphocytes circulating to the gastr
Externí odkaz:
https://doaj.org/article/b2995644ed9f4c96bffe9657f67e3707